Table 1 Demographic and clinical features of the study patients

ReA (n = 6)

2 (1–6)

35 (20–50)

5:1

   1

28

M

Sexually acquired ReA;Ct IgG positive serology^a; Ct-positive PCR^b

   2

22

M

Sexually acquired ReA; Ct IgG positive^a

   3

40

F

Sexually acquired ReA; Ct IgG positive serology^a

   4

20

M

Sexually acquired ReA; Ct IgG positive serology^a; B27+^c

   5

50

M

Sexually acquired ReA; Ct IgG positive serology^a; Ct positive PCR^b; B27+

6

30

M

Sexually-acquired ReA; Ct IgG positive serology^a

UA (n = 9)

25 (2–60)

40 (22–59)

5:4

-

RA (n = 7)

66 (12–228)

44 (39–53)

2:5

-

OA (n = 6)

14 (12–24)

58 (44–70)

5:1

-